![Philippe Martin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Philippe Martin
Hoofd Techniek/Wetenschap/O&O bij
VIATRIS INC.
Profiel
Philippe Martin is currently the Chief Research & Development Officer at Viatris, Inc. He previously worked as the VP-Project Leadership & Project Management at Celgene Corp from 2014 to 2016 and as the Chief Clinical Development & Operations Officer at BioAtla, Inc. from 2018 to 2023.
Mr. Martin holds an MBA from EM Lyon Business School.
Actieve functies van Philippe Martin
| Bedrijven | Functie | Begin |
|---|---|---|
| VIATRIS INC. | Hoofd Techniek/Wetenschap/O&O | 15-12-2023 |
Eerdere bekende functies van Philippe Martin
| Bedrijven | Functie | Einde |
|---|---|---|
| BIOATLA, INC. | Operationeel Directeur | 01-09-2023 |
| CELGENE | Corporate Officer/Principal | 04-06-2016 |
Opleiding van Philippe Martin
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
54
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
EM Lyon Business School
 EM Lyon Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioAtla, Inc.
 BioAtla, Inc. BiotechnologyHealth Technology Develops novel monoclonal antibody and protein therapeutic products | Health Technology |
Viatris, Inc.
 Viatris, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
